Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin and Pioglitazone HCL Combination Therapy in Amyotrophic Lateral Sclerosis
NCT00919555Phase 2Completed
- Sponsor
- Phoenix Neurological Associates
- Start
- Jun 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin, pioglitazone in amyotrophic lateral sclerosis (ALS), sponsored by Phoenix Neurological Associates. Started Jun 2008; status: completed.
02
Drugs
tretinoinpioglitazone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00919555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919555.